Nisa Investment Advisors
FOLD

Nisa Investment Advisors’s Amicus Therapeutics FOLD Stock Holding History

Nisa Investment Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.6K Buy
4,122
+1,235
+43% +$17.7K ﹤0.01% 1596
2025
Q4 		$41.1K Hold
2,887
– – ﹤0.01% 1680
2025
Q3 		$22.8K Sell
2,887
-61
-2% -$434 ﹤0.01% 1937
2025
Q2 		$16.9K Sell
2,948
-3,572
-55% -$23.1K ﹤0.01% 2024
2025
Q1 		$53.2K Buy
6,520
+108
+2% +$999 ﹤0.01% 1574
2024
Q4 		$60.4K Sell
6,412
-358
-5% -$3.72K ﹤0.01% 1629
2024
Q3 		$72.3K Sell
6,770
-1,351
-17% -$14.7K ﹤0.01% 1538
2024
Q2 		$80.6K Buy
8,121
+279
+4% +$2.86K ﹤0.01% 1529
2024
Q1 		$92.4K Buy
7,842
+200
+3% +$2.56K ﹤0.01% 1491
2023
Q4 		$108K Buy
7,642
+32
+0.4% +$363 ﹤0.01% 1419
2023
Q3 		$92.5K Hold
7,610
– – ﹤0.01% 1528
2023
Q2 		$95.6K Sell
7,610
-20
-0.3% -$237 ﹤0.01% 1521
2023
Q1 		$85K Hold
7,630
– – ﹤0.01% 1551
2022
Q4 		$93K Hold
7,630
– – ﹤0.01% 1575
2022
Q3 		$77K Buy
7,630
+190
+3% +$2.12K ﹤0.01% 1593
2022
Q2 		$80K Sell
7,440
-1,140
-13% -$9.39K ﹤0.01% 1565
2022
Q1 		$81K Sell
8,580
-710
-8% -$6.66K ﹤0.01% 1693
2021
Q4 		$87K Sell
9,290
-1,440
-13% -$16K ﹤0.01% 1570
2021
Q3 		$102 Hold
10,730
– – ﹤0.01% 1693
2021
Q2 		$103 Buy
10,730
+8,300
+342% +$81K ﹤0.01% 1679
2021
Q1 		$24 Sell
2,430
-7,900
-76% -$122K ﹤0.01% 2099
2020
Q4 		$239K Buy
10,330
+1,400
+16% +$28.6K ﹤0.01% 1397
2020
Q3 		$126K Buy
8,930
+6,900
+340% +$101K ﹤0.01% 1474
2020
Q2 		$31K Buy
2,030
+210
+12% +$2.56K ﹤0.01% 1679
2020
Q1 		$17K Sell
1,820
-1,450
-44% -$13.8K ﹤0.01% 1733
2019
Q4 		$32K Buy
3,270
+1,940
+146% +$17.8K ﹤0.01% 1602
2019
Q3 		$11K Buy
1,330
+410
+45% +$4.45K ﹤0.01% 1760
2019
Q2 		$11K Hold
920
– – ﹤0.01% 1725
2019
Q1 		$13K Hold
920
– – ﹤0.01% 1686
2018
Q4 		$9K Hold
920
– – ﹤0.01% 1671
2018
Q3 		$11K Sell
920
-490
-35% -$6.85K ﹤0.01% 1693
2018
Q2 		$22K Buy
1,410
+210
+18% +$3.17K ﹤0.01% 1526
2018
Q1 		$18K Sell
1,200
-460
-28% -$7K ﹤0.01% 1498
2017
Q4 		$24K Hold
1,660
– – ﹤0.01% 1510
2017
Q3 		$25K Hold
1,660
– – ﹤0.01% 1487
2017
Q2 		$17K Buy
1,660
+700
+73% +$5.63K ﹤0.01% 1528
2017
Q1 		$7K Sell
960
-840
-47% -$5.31K ﹤0.01% 1757
2016
Q4 		$9K Buy
+1,800
New +$12.5K ﹤0.01% 1815

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Nisa Investment Advisors's FOLD Position: Q1 2026 in Review

Nisa Investment Advisors increased its Amicus Therapeutics (FOLD) stake by 43% in Q1 2026, buying an estimated $17.7K and bringing the position to 4,122 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

Nisa Investment Advisors first reported a position in FOLD in Q4 2016 and has held it in 38 quarters since. The position peaked at $239K in Q4 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Nisa Investment Advisors held 4,122 shares of Amicus Therapeutics worth $59.6K as of Q1 2026.
  • Nisa Investment Advisors bought 1,235 Amicus Therapeutics shares in Q1 2026, an estimated $17.7K.
  • Amicus Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1596 holding.
  • Nisa Investment Advisors first reported a position in Amicus Therapeutics in Q4 2016 and has held it in 38 quarters since.
  • Nisa Investment Advisors's Amicus Therapeutics position peaked at $239K in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.